AstraZeneca has closed the previously announced $1.8 billion acquisition of US biopharmaceutical company CinCor Pharma. Under the terms of the agreement, AstraZeneca acquired all outstanding shares as well as the cash and marketable securities of CinCor Pharma for approximately $1.3bn upfront and around $500 million, respectively. Last month, AstraZeneca announced a definitive agreement to acquire […]
Pharma giant AstraZeneca has closed the previously announced acquisition of Neogene Therapeutics, a US-based clinical-stage biotechnology company. Neogene Therapeutics is engaged in the discovery, development, and manufacturing of next-generation T-cell receptor therapies (TCR-Ts). AstraZeneca announced the deal to acquire the cell therapy company in November 2022 and offered a consideration of up to $320 million. […]
AstraZeneca will acquire Neogene Therapeutics, a US-based clinical-stage biotechnology company, for a total consideration of up to $320 million, bringing next-generation transformative cell therapies for cancer treatment. The value of the transaction constitutes an initial payment of $200 million on post-closing and an additional payment of up to $120 million on hitting a certain number […]